Related Experiment Videos
Angiogenesis in embryonic development--a review.
1Max-Planck Institut for Physiological and Clinical Research, Laboratory of Molecular and Cellular Biology, Bad Nauheim, Germany. g.breier@kerckhoff.mpg.de
Placenta
|June 1, 2000
Summary
Genetically altered mice reveal key molecular regulators of vascular system development. Understanding endothelial signaling pathways like VEGF and angiopoietin is crucial for embryonic angiogenesis research.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- The development of the vascular system is a complex process.
- Genetically modified mouse models have significantly advanced our knowledge of vascular development.
- Endothelial cell signaling pathways play critical roles in regulating blood vessel formation.
Purpose of the Study:
- To elucidate the molecular mechanisms governing vascular system development.
- To identify key signaling systems involved in embryonic angiogenesis.
- To explore the intricate interactions among various endothelial signaling pathways.
Main Methods:
- Utilized genetically altered mouse models.
- Investigated endothelial signaling pathways, including vascular endothelial growth factor (VEGF)/VEGF receptor and angiopoietin/Tie2 systems.
- Analyzed the molecular basis of embryonic angiogenesis.
Main Results:
- Identified the vascular endothelial growth factor (VEGF)/VEGF receptor system as a central regulator of embryonic angiogenesis.
- Identified the angiopoietin/Tie2 system as a key regulator in embryonic angiogenesis.
- Began to uncover complex interactions between these and other endothelial signaling systems.
Conclusions:
- The vascular endothelial growth factor (VEGF)/VEGF receptor and angiopoietin/Tie2 systems are fundamental to embryonic angiogenesis.
- Further research is needed to fully understand the complex interplay of endothelial signaling in vascular development.
- Genetically altered mice are powerful tools for dissecting the molecular underpinnings of angiogenesis.